Skip to main content
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis.
The gut microbiome in human neurological disease: A review.
Precision medicine in chronic disease management: The multiple sclerosis BioScreen.
Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
Early detection of thrombin activity in neuroinflammatory disease.
Quo vadis? Peering into the future.
Have the Annals editors added value?
Acute seizures predict epilepsy after childhood stroke.
Recent trauma and acute infection as risk factors for childhood arterial ischemic stroke.
Genetic deletion of CD36 enhances injury after acute neonatal stroke.